Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, registration directed Phase II study

Nathan H. Fowler; Felipe Samaniego; Wojciech Jurczak; Ewa Lech-Maranda; Nilanjan Ghosh; Bertrand Anz; Piers Patten; James A. Reeves; Lori A. Leslie; Piotr Smolewski; Julio C. Chavez; Paolo Ghia; Corrado Tarella; John M. Burke; Jeff Sharman; Kathryn Kolibaba; Owen A. O'Connor; Chan Y. Cheah; Hari P. Miskin; Peter Sportelli; Michael S. Weiss; Pier Luigi Zinzani

doi:10.1158/1538-7445.AM2019-CT132

Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, registration directed Phase II study

Nathan H. Fowler, Felipe Samaniego, Wojciech Jurczak, Ewa Lech-Maranda, Nilanjan Ghosh, Bertrand Anz, Piers Patten, James A. Reeves, Lori A. Leslie, Piotr Smolewski, Julio C. Chavez, Paolo Ghia, Corrado Tarella, John M. Burke, Jeff Sharman, Kathryn Kolibaba, Owen A. O'Connor, Chan Y. Cheah, Hari P. Miskin, Peter SportelliMichael S. Weiss, Pier Luigi Zinzani

Pathology & Laboratory Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Number of pages	3
Journal	Cancer Research
Volume	79
Issue number	13
DOIs	https://doi.org/10.1158/1538-7445.AM2019-CT132
Publication status	Published - Jul 2019
Event	Annual Meeting of the American-Association-for-Cancer-Research (AACR) - Atlanta, United States Duration: 29 Mar 2019 → 3 Apr 2019

Access to Document

10.1158/1538-7445.AM2019-CT132

Cite this

Fowler, N. H., Samaniego, F., Jurczak, W., Lech-Maranda, E., Ghosh, N., Anz, B., Patten, P., Reeves, J. A., Leslie, L. A., Smolewski, P., Chavez, J. C., Ghia, P., Tarella, C., Burke, J. M., Sharman, J., Kolibaba, K., O'Connor, O. A., Cheah, C. Y., Miskin, H. P., ... Zinzani, P. L. (2019). Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, registration directed Phase II study. Cancer Research, 79(13). https://doi.org/10.1158/1538-7445.AM2019-CT132

@article{421b58579cd14d1295f69feb7adee05f,

title = "Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, registration directed Phase II study",

author = "Fowler, {Nathan H.} and Felipe Samaniego and Wojciech Jurczak and Ewa Lech-Maranda and Nilanjan Ghosh and Bertrand Anz and Piers Patten and Reeves, {James A.} and Leslie, {Lori A.} and Piotr Smolewski and Chavez, {Julio C.} and Paolo Ghia and Corrado Tarella and Burke, {John M.} and Jeff Sharman and Kathryn Kolibaba and O'Connor, {Owen A.} and Cheah, {Chan Y.} and Miskin, {Hari P.} and Peter Sportelli and Weiss, {Michael S.} and Zinzani, {Pier Luigi}",

year = "2019",

month = jul,

doi = "10.1158/1538-7445.AM2019-CT132",

language = "English",

volume = "79",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research (AACR)",

number = "13",

note = "Annual Meeting of the American-Association-for-Cancer-Research (AACR), AACR ; Conference date: 29-03-2019 Through 03-04-2019",

}

Fowler, NH, Samaniego, F, Jurczak, W, Lech-Maranda, E, Ghosh, N, Anz, B, Patten, P, Reeves, JA, Leslie, LA, Smolewski, P, Chavez, JC, Ghia, P, Tarella, C, Burke, JM, Sharman, J, Kolibaba, K, O'Connor, OA, Cheah, CY, Miskin, HP, Sportelli, P, Weiss, MS & Zinzani, PL 2019, 'Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, registration directed Phase II study', Cancer Research, vol. 79, no. 13. https://doi.org/10.1158/1538-7445.AM2019-CT132

Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open-label, registration directed Phase II study. / Fowler, Nathan H.; Samaniego, Felipe; Jurczak, Wojciech et al.
In: Cancer Research, Vol. 79, No. 13, 07.2019.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma

T2 - Annual Meeting of the American-Association-for-Cancer-Research (AACR)

AU - Fowler, Nathan H.

AU - Samaniego, Felipe

AU - Jurczak, Wojciech

AU - Lech-Maranda, Ewa

AU - Ghosh, Nilanjan

AU - Anz, Bertrand

AU - Patten, Piers

AU - Reeves, James A.

AU - Leslie, Lori A.

AU - Smolewski, Piotr

AU - Chavez, Julio C.

AU - Ghia, Paolo

AU - Tarella, Corrado

AU - Burke, John M.

AU - Sharman, Jeff

AU - Kolibaba, Kathryn

AU - O'Connor, Owen A.

AU - Cheah, Chan Y.

AU - Miskin, Hari P.

AU - Sportelli, Peter

AU - Weiss, Michael S.

AU - Zinzani, Pier Luigi

PY - 2019/7

Y1 - 2019/7

U2 - 10.1158/1538-7445.AM2019-CT132

DO - 10.1158/1538-7445.AM2019-CT132

M3 - Abstract/Meeting Abstract

SN - 0008-5472

VL - 79

JO - Cancer Research

JF - Cancer Research

IS - 13

Y2 - 29 March 2019 through 3 April 2019

ER -